KR Choksey's research report on HDFC Life Insurance Co
The Gross written premium for Q3FY23 stood at INR 1,45,750 Mn, healthy growth of 18.9% YoY/ 9.7% QoQ led by strong growth of 29.7% YoY in the renewal premium. The New Business Premium for the quarter grew by 10.1% YoY/ 15.9% QoQ driven by 28.8% YoY/ 12.5% QoQ in First-Year Premium segment. The single premium segment grew by 1.5% YoY in Q3FY23. New business margin (NBM) expanded by 74 bps QoQ (-8 bps YoY) at 26.7% in Q2FY23 for the merged entity. The value of the new business increased to INR 8,700 Mn, registering a QoQ growth of 11.5% (25.4% YoY) in Q3FY23. PAT for Q3FY23 was at INR 3,152 Mn, a growth of 15.2% vs Q3FY22. Solvency ratio as of September 30, 2022, stood at 209%. AUM as of December 31, 2022, stood at INR 23,38,390 Mn, a growth of 20.1% YoY (14.4% QoQ). The embedded value of the merged entity is INR 377.02 Bn as of December 31, 2022.
Outlook
We assign a 3.3x P/EV on FY24E EVPS of INR 227.0, a VNB multiple of 18x to HDFC Life, and arrive at the weighted average Target Price at INR 735 per share (Earlier INR 706) (50:50 weights on the P/EV and appraisal value methodology), implying a 24.9% upside potential over CMP. We have maintained our 'BUY' rating on HDFC Life Insurance Co. Ltd.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!